15 reports

Top ## players hold majority of stake in the market ##.

  • Cardiovascular Disease
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.

The molecules developed by Companies in Phase III, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Cardiovascular Disease
  • Pathology
  • World
  • Product Initiative
  • Evotec AG
  • VY-OZ - DRUG PROFILE

Anakinra blocks the biologic activity of interleukin-## by competitively inhibiting interleukin-## binding to the interleukin-## type I receptor (IL ##RI), which is expressed in a wide variety of tissues and organs.

  • Cardiovascular Disease
  • Pathology
  • World
  • Product Initiative
  • Evotec AG

MOREOVER, THERE CAN ALSO BE SIDE EFFECTS ARISING FROM ERRORS SUCH AS DISPLACED ELECTRODES, WHICH CAN LEAD TO STROKE, ENCEPHALITIS, OR INFECTION IN THE BRAIN.

  • Cardiovascular Disease
  • North America
  • United States
  • World
  • Market Size

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Cardiovascular Disease
  • Heart Failure
  • In Vitro Diagnostic Reagent
  • United States
  • bioMerieux S.A.
  • R&D Progress
  • MYOCARDIAL INFARCTION - PIPELINE BY ATHERSYS INC, H2 2018

Myocardial Infarction - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H2 2018, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction...

  • Cardiovascular Disease
  • Heart Attack
  • United States
  • Company
  • Product Initiative
  • POLYGLACTIN 370 FOR MYOCARDIAL INFARCTION - DRUG PROFILE
  • MYOCARDIAL INFARCTION - PIPELINE BY ATHERSYS INC, H1 2018

It provides vaccines and therapeutics for various infections such as Japanese encephalitis, diphtheria and others.

  • Cardiovascular Disease
  • Cell Therapy
  • United States
  • World
  • Product Initiative

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Cardiovascular Disease
  • Clinical Trial
  • Healthcare
  • United States
  • GlobalData's company

ZYAN-## acts as PHD-## inhibitor.

  • Cardiovascular Disease
  • Chronic Pain
  • Healthcare
  • Infectious Disease
  • Cadila Healthcare Ltd

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Cardiovascular Disease
  • Clinical Trial
  • Diagnostics
  • United States
  • GlobalData's company

Antiviral activity was also observed against other flaviviruses such as the yellow fever virus and the tick-borne encephalitis virus (TBEV).

  • Cardiovascular Disease
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States

COMPANY EXPECTS TO INVESTIGATE THE DRUG CANDIDATE FOR THE TREATMENT OF OTHER FORMS OF HEPATITIS, VIRAL ENCEPHALITIS AND HIV.

  • Cardiovascular Disease
  • Chronic Disease
  • United States
  • Product Initiative
  • Amarin Corporation plc

PARTNER ##: AMGEN, INC.

  • Cardiovascular Disease
  • Chronic Disease
  • Healthcare
  • Pharmaceutical
  • MedImmune, LLC

BioFire Diagnostics, a bioMérieux company, received clearance from the FDA for the FilmArray Meningitis/ Encephalitis (ME) Panel.

  • Cardiovascular Disease
  • Diabetes
  • North America
  • United States
  • Roche Group
  • POLYGLACTIN 370 FOR ISCHEMIC STROKE - DRUG PROFILE

The company reported that the drug candidate has been FDA approved for orphan drug designation for the treatment of acute encephalitis syndrome.

  • Cardiovascular Disease
  • Neurological Disorder
  • United States
  • Company
  • Product Initiative